Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610).
CompletedOBSERVATIONAL
Enrollment
178
Participants
Timeline
Start Date
June 30, 2006
Primary Completion Date
November 30, 2011
Study Completion Date
November 30, 2011
Conditions
Non-Hodgkin's LymphomaAutologous Transplantation
Interventions
DRUG
granulocyte colony-stimulating factor (G-CSF)
DRUG
plerixafor
DRUG
Placebo
All Listed Sponsors
lead
Genzyme, a Sanofi Company
INDUSTRY
NCT00741325 - Long-Term Follow-up Study for Non-Hodgkin's Lymphoma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3101 Study (NCT00103610). | Biotech Hunter | Biotech Hunter